 |
|
|
SEER Description — Seer Inc
Seer is a life sciences company focused on capturing molecular insights from the proteome to enable insights in the understanding of biology and disease. Co. has focused its efforts mainly to research, development and commercialization of its technology and products. Co.'s product, the Proteograph Product Suite (Proteograph), uses its proprietary engineered nanoparticle technology to provide access to the proteome. The Proteograph Product Suite is an integrated solution that is comprised of consumables, an automation instrument and software. Co. is initially focused on research applications for the Proteograph Product Suite and is selling and marketing the Proteograph for research use only.
| Company Name: |
Seer Inc |
| Website: |
www.seer.bio |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding SEER: |
14 |
| Total Market Value Held by ETFs: |
$10,504,149 |
| Total Market Capitalization: |
$136,000,000 |
| % of Market Cap. Held by ETFs: |
7.72% |
|
| ETF |
SEER Weight |
SEER Amount |
| VTI |
0.00% |
$3,459,099 |
| IWM |
0.00% |
$2,990,993 |
| IWN |
0.01% |
$1,192,066 |
| VXF |
0.00% |
$1,122,682 |
| PRFZ |
0.02% |
$502,520 |
| VTWO |
0.00% |
$472,429 |
| VHT |
0.00% |
$331,023 |
| IWC |
0.03% |
$270,883 |
| VTWV |
0.01% |
$91,416 |
| IWV |
0.00% |
$40,978 |
| List of all 14 ETFs holding SEER
» |
|
|
|
|
|
Buy (2.67 out of 4)
10th percentile
|
PARTNER NEWS:Fri, Feb 2, 8:55 AM, Zacks
Here's Why Seer, Inc. (SEER) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for Seer, Inc. (SEER), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
|
|
Free SEER Email Alerts:
